Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB4 reduction but not PGE(2) increment

Full text
Show less -
Sorgi, Carlos Arterio [1] ; Soares, Elyara Maria [1] ; Rosada, Rogerio Silva [2] ; Bitencourt, Claudia Silva [1] ; Zoccal, Karina Furlani [1] ; Tartari Pereira, Priscilla Aparecida [1] ; Fontanari, Caroline [1] ; Brandao, Izaira [2] ; Masson, Ana Paula [2] ; Ramos, Simone Gusmao [3] ; Silva, Cello Lopes [2] ; Frantz, Fabiani Gai [1] ; Faccioli, Lucia Helena [1]
Total Authors: 13
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Ribeirao Preto, SP - Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP - Brazil
[3] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Patol, Ribeirao Preto, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Web of Science Citations: 0

The functions of eicosanoids, a family of potent biologically active lipid mediators, are not restricted to inflammatory responses and they also act as mediators of the pathogenesis process. However, the role of eicosanoids in tuberculosis remains controversial. To investigate the specific role of LTB4 in Mycobacterium tuberculosis (Mtb) infection, we used 5-lipoxygenase-deficient (5-LO-/-) mice and WT (sv129) mice inoculated intranasally with LTB4 (encapsulated in PLGA microspheres). We showed that deficiency of the 5-LO pathway was related to resistance to Mtb infection. LTB4 inoculation increased susceptibility to Mtb in 5-LO-/- mice but not in WT mice, resulting in worsening of lung inflammation and tissue damage. In infected WT mice, most supplementary LTB4 was metabolized to the inactive form 12-oxo-LTB4 in the lung. A high amount of PGE(2) was detected during Mtb infection, and pharmacological inhibition of COX-2 induced a significant reduction of bacterial load and an improved innate immune response in the lungs, independently of baseline LTB4 levels. COX-2 inhibition with celecoxib significantly reduced PGE(2) levels, enhanced IFN-gamma production and NO release, and increased macrophage phagocytosis of Mtb. The results suggest that a balance between PGE(2)/LTB4 is essential in the pathogenesis process of tuberculosis to prevent severe inflammation. Moreover, optimal levels of PGE(2) are required to induce an effective innate response in the early phase of Mtb infection. Thus, pharmacological modulation of eicosanoid production may provide an important host-directed therapy in tuberculosis. (AU)

FAPESP's process: 10/11239-6 - In vitro and in vivo effects of exogenous Leukotriene B4 during Mycobacterium tuberculosis experimental infection
Grantee:Fabiani Gai Frantz
Support type: Scholarships in Brazil - Post-Doctorate
FAPESP's process: 15/00658-1 - New functional aspects of eicosanoids
Grantee:Lúcia Helena Faccioli
Support type: Multi-user Equipment Program
FAPESP's process: 09/07169-5 - Lipid mediators as regulators of immune response
Grantee:Lúcia Helena Faccioli
Support type: Research Projects - Thematic Grants